Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population. - Intapiboon P; Seepathomnarong P; Ongarj J; Surasombatpattana S; Uppanisakorn S; Mahasirimongkol S; Sawaengdee W; Phumiamorn S; Sapsutthipas S; Sangsupawanich P; Chusri S; Pinpathomrat N (Vaccines, 2021)